Endothelial dysfunction is associated with the severity of cerebral small vessel disease

被引:75
|
作者
Nezu, Tomohisa [1 ]
Hosomi, Naohisa [1 ]
Aoki, Shiro [1 ]
Kubo, Satoshi [1 ]
Araki, Mutsuko [1 ]
Mukai, Tomoya [1 ]
Takahashi, Tetsuya [1 ]
Maruyama, Hirofumi [1 ]
Higashi, Yukihito [2 ]
Matsumoto, Masayasu [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Res Ctr Radiat Genome Med, Dept Cardiovasc Regenerat & Med, Hiroshima 7348551, Japan
基金
日本科学技术振兴机构;
关键词
cerebral microbleeds; cerebral small vessel disease; endothelial dysfunction; white matter lesions; WHITE-MATTER LESIONS; POSITRON-EMISSION-TOMOGRAPHY; FLOW-MEDIATED VASODILATION; ARTERY OCCLUSIVE DISEASE; ISCHEMIC-STROKE; VASOMOTOR REACTIVITY; INTRACEREBRAL HEMORRHAGE; ACETAZOLAMIDE REACTIVITY; CEREBROVASCULAR-DISEASE; OXYGEN-METABOLISM;
D O I
10.1038/hr.2015.4
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The pathogenesis of cerebral small vessel disease, a disease that involves white matter lesions (WMLs) and cerebral microbleeds (CMBs), is thought to be associated with endothelial dysfunction. Flow-mediated dilation (FMD) has been used to measure endothelium-dependent vasodilation. The aim of this study was to investigate the association between endothelial function (as measured by FMD) and cerebral small vessel disease. Patients with a history of cerebrovascular disease and comorbidities were enrolled in this study (n= 102; 69 males, 70.1 +/- 9.2 years). The patients were divided into two groups according to the severity of WMLs, which were assessed by Fazekas classification; grades 0 to 1 as mild WMLs group and grades 2 to 3 as severe WMLs group. A gradient-echo MRI was performed in 96 patients (94.1%) to evaluate whether CMBs were present. The patients in the severe WMLs group (n= 40) were older (P = 0.001), more frequently exhibited hypertension (P = 0.045) and diabetes mellitus (P = 0.026) and possessed lower FMD values (P<0.001) than the patients in the mild WMLs group (n= 62). CMBs were observed in 30 patients (31.3%). Using receiver operating characteristic curves, the optimal FMD cutoff values for predicting the presence of severe WMLs and CMBs were 3.9% and 3.7%, respectively. On multivariate logistic analysis, FMD <4.0% (odds ratio 9.50; 95% confidence interval 3.55-28.83) was independently associated with severe WMLs. Additionally, FMD <3.8% (5.82; 2.23-16.50) was also associated with the presence of CMBs. Endothelial dysfunction as evaluated by FMD may be predictive of the severity of cerebral small vessel disease.
引用
收藏
页码:291 / 297
页数:7
相关论文
共 50 条
  • [1] Endothelial dysfunction is associated with the severity of cerebral small vessel disease
    Tomohisa Nezu
    Naohisa Hosomi
    Shiro Aoki
    Satoshi Kubo
    Mutsuko Araki
    Tomoya Mukai
    Tetsuya Takahashi
    Hirofumi Maruyama
    Yukihito Higashi
    Masayasu Matsumoto
    [J]. Hypertension Research, 2015, 38 : 291 - 297
  • [2] Endothelial dysfunction on cerebral small vessel disease
    Medina, M.
    Sander, L.
    Moncada, S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [3] A Vessel for Change: Endothelial Dysfunction in Cerebral Small Vessel Disease
    Quick, Sophie
    Moss, Jonathan
    Rajani, Rikesh M.
    Williams, Anna
    [J]. TRENDS IN NEUROSCIENCES, 2021, 44 (04) : 289 - 305
  • [4] Endothelial dysfunction in patients with cerebral small vessel disease
    Kim, Yosik
    Park, Hyun-Young
    Kim, Nam-Ho
    Park, Man-Seok
    Cho, Ki-Hyun
    [J]. STROKE, 2007, 38 (02) : 568 - 568
  • [5] Endothelial dysfunction in patients with cerebral small vessel disease
    Kim, Y. S.
    Park, H. X.
    Kim, N. H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 49 - 50
  • [6] CIRCULATING BIOMARKERS OF ENDOTHELIAL DYSFUNCTION IN CEREBRAL SMALL VESSEL DISEASE
    Tanriverdi, U.
    Gurel, C. Bayram
    Ayaz, G.
    Ulutin, T.
    Arslan, S.
    Kizilkilic, O.
    Ince, F. B.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 41 - 41
  • [7] Carotid Atheroinflammation Is Associated With Cerebral Small Vessel Disease Severity
    Evans, Nicholas R.
    Tarkin, Jason M.
    Walsh, Jessica
    Chowdhury, Mohammed M.
    Patterson, Andrew J.
    Graves, Martin J.
    Rudd, James H. F.
    Warburton, Elizabeth A.
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [8] Homocysteine and cerebral small vessel disease: A potential disease mechanism through endothelial dysfunction
    Hassan, A
    O'Sullivan, M
    De Souza, R
    Bamford, J
    Briley, D
    Brown, M
    Thomas, D
    Markus, H
    [J]. STROKE, 2003, 34 (01) : 293 - 293
  • [9] Homocysteine and cerebral small vessel disease: A potential disease mechanism through endothelial dysfunction
    Hassan, A
    O'Sullivan, M
    de Souza, R
    Bamford, J
    Briley, D
    Brown, M
    Thomas, D
    Markus, H
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03): : 401 - 401
  • [10] Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review
    Poggesi, Anna
    Pasi, Marco
    Pescini, Francesca
    Pantoni, Leonardo
    Inzitari, Domenico
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (01): : 72 - 94